Farnesoid X receptor protects against lipopolysaccharide-induced endometritis by inhibiting ferroptosis and inflammatory response
International Immunopharmacology · 2023-05 · 118 · 110080
DOI: 10.1016/j.intimp.2023.110080 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-05. Verfasst von Lu Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, China-Japan Union Hospital of Jilin University, Erdao District, 126 Sendai Street, Changchun, Jilin Province 130033, China. Hauptthemen laut MEDLINE: Endometritis, Ferroptosis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Endometritis is an inflammatory condition that affects the endometrium; it is induced by bacterial infection and often leads to infertility and repeated abortions. Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that mediates a variety of inflammatory diseases. In the present study, we determined the protective effects of FXR on lipopolysaccharide (LPS)-induced endometritis in mice and the underlying mechanisms. The results showed that LPS administration reduced the expression of FXR in the uterus, and treatment with the FXR agonist GW4064 and fexaramine significantly alleviated the endometritis induced by LPS. In addition, compared with wild-type (WT) mice, FXR-knockout mice had more severe inflammatory responses in their uteri after LPS treatment. Moreover, ferroptosis was increased during LPS-induced endometritis, as shown by increased levels of malondialdehyde (MDA) and iron, and decreased levels of superoxide dismutase (SOD), glutathione (GSH), GXP4 and SLC7A11. In addition, inhibition of ferroptosis by treatment with ferrostation-1 (Fer-1) and liproxstatin (Lip-1) alleviated LPS-induced endometritis. Additionally, FXR-knockout mice were used to determine the relationship between FXR and ferroptosis. The results showed that knockout of FXR induced ferroptosis, and an FXR agonist inhibited LPS-induced ferroptosis. Finally, the regulatory effects of obeticholic acid (OCA) on FXR/ferroptosis and endometritis were assessed. The results showed that treatment with OCA increased the expression of FXR, decreased the levels of ferroptosis, and inhibited the endometritis induced by LPS. In conclusion, the results showed that activation of FXR can alleviate LPS-induced endometritis by inhibiting ferroptosis, and FXR may be a potential therapeutic target for treating endometritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, China-Japan Union Hospital of Jilin University, Erdao District, 126 Sendai Street, Changchun, Jilin Province 130033, China.
- Department of Gynecology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China.
- Department of Gynecology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China. Electronic address: junbao@mail.jlu.edu.cn.
Zitieren
APA
Cao, L., Qin, R., & Liu, J. (2023). Farnesoid X receptor protects against lipopolysaccharide-induced endometritis by inhibiting ferroptosis and inflammatory response. International Immunopharmacology, 118, 110080. https://doi.org/10.1016/j.intimp.2023.110080
Vancouver
Cao L, Qin R, Liu J. Farnesoid X receptor protects against lipopolysaccharide-induced endometritis by inhibiting ferroptosis and inflammatory response. International Immunopharmacology. 2023;118:110080. doi:10.1016/j.intimp.2023.110080
BibTeX
@article{Cao2023,
author = {Cao, Lu and Qin, Rui and Liu, Junbao},
title = {Farnesoid X receptor protects against lipopolysaccharide-induced endometritis by inhibiting ferroptosis and inflammatory response},
journal = {International Immunopharmacology},
year = {2023},
volume = {118},
pages = {110080},
doi = {10.1016/j.intimp.2023.110080}
}
EUVIMED